Location: Champalimaud Centre for the Unknown, Lisbon
Employer: Champalimaud Foundation
Job Type: Full Time
Position: Postdoctoral Positions

Application Starts: 09 Nov. 2021
Application Ends: 25 Nov. 2021

Champalimaud Foundation (Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud), a private, non-profit research institution in Lisbon, Portugal, is looking for a Research Technician to join our team.

Call reference: procancer tech PnK Nov2021
Work Plan
– Participate on the development of Deep Learning based models and Radiomics Signatures that will be extracted from mpMRI images from a total number of 17000 patients with prostate cancer, with a focus on statistical analysis concepts including but not limited to feature selection/reduction, ML modelling using survival analysis and other clinical outcomes. The candidate will also provide project management services to synchronize the different clinical units involved in the project.

Skills/ Qualifications
Minimum qualifications
– 1st degree in Biomedical Engineering;
– M.Sc. on a topic relative to prostate cancer and medical imaging.

Essential skills
– Quantitative Medical Imaging expertise.

Desirable skills that will also be considered
– Prior experience on European funded projects.

Primary location of work
Champalimaud Center for the Unknown

Source of financing
ProCancer-I (952159)

Highlights

ProCAncer-I at the EMUC24 in Lisbon

ProCAncer-I at the EMUC24 in Lisbon

The progress of major trials, the advent of artificial intelligence (AI), and interdisciplinary best practices will comprise the scientific programme of the 16th European Multidisciplinary Congress on Urological Cancers (EMUC24), which will take place from 7 to 10...

Third Dissemination Event of the ProCAncer-I Project in Athens

Third Dissemination Event of the ProCAncer-I Project in Athens

ProCAncer-I organised the 3rd Dissemination Event of the project at the 21st IEEE International Symposium on Biomedical Imaging, held in Athens, Greece, May 27-30, 2024. During the symposium, ProCAncer-I organised the Workshop “Integrating imaging Data and AI models...

AI in PCa imaging : The current status and future perspectives

AI in PCa imaging : The current status and future perspectives

Ιn recent years, magnetic resonance imaging (MRI) has transformed the prostate cancer (PCa) diagnostic pathway, based on the evidence of multiple high-level evidence studies (refs 4M, MRI first, and PROMIS). Taken together, the evidence indicates that prostate MRI...

Twitter feed is not available at the moment.

Stay in touch!